Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -2.14% vs 40.13% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -20.40% vs -4.80% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -54.44% vs 34.86% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -100.00% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Hefei Lifeon Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.45% vs 4.93% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -2.14% vs 40.13% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -39.58% vs 33.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -20.40% vs -4.80% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -47.78% vs -2.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -54.44% vs 34.86% in Sep 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






